Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin

Hexokinase 2 (HK2) is selectively upregulated in hepatocellular carcinoma (HCC). Here the authors show that HK2 ablation decreases glycolysis and triggers oxidative phosphorylation (OXPHO) rendering HCC more susceptible to the OXPHO inhibitor metformin and to the FDA-approved drug sorafenib.

Dettagli Bibliografici

Autori principali:	Dannielle DeWaal, Veronique Nogueira, Alexander R. Terry, Krushna C. Patra, Sang-Min Jeon, Grace Guzman, Jennifer Au, Christopher P. Long, Maciek R. Antoniewicz, Nissim Hay
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Nature Portfolio 2018-01-01
Serie:	Nature Communications
Accesso online:	https://doi.org/10.1038/s41467-017-02733-4
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!